Published in FEMS Microbiol Lett on August 01, 2008
The genome of a pathogenic rhodococcus: cooptive virulence underpinned by key gene acquisitions. PLoS Genet (2010) 1.36
Streptomyces temperate bacteriophage integration systems for stable genetic engineering of actinomycetes (and other organisms). J Ind Microbiol Biotechnol (2011) 1.12
A novel method to generate unmarked gene deletions in the intracellular pathogen Rhodococcus equi using 5-fluorocytosine conditional lethality. Nucleic Acids Res (2008) 1.10
Characterization of the role of the pathogenicity island and vapG in the virulence of the intracellular actinomycete pathogen Rhodococcus equi. Infect Immun (2010) 0.91
Conjugal transfer of a virulence plasmid in the opportunistic intracellular actinomycete Rhodococcus equi. J Bacteriol (2012) 0.84
IcgA is a virulence factor of Rhodococcus equi that modulates intracellular growth. Infect Immun (2014) 0.81
VirS, an OmpR/PhoB subfamily response regulator, is required for activation of vapA gene expression in Rhodococcus equi. BMC Microbiol (2014) 0.80
Transcriptome reprogramming by plasmid-encoded transcriptional regulators is required for host niche adaption of a macrophage pathogen. Infect Immun (2015) 0.79
Influence of Plasmid Type on the Replication of Rhodococcus equi in Host Macrophages. mSphere (2016) 0.75
Genome Integration and Excision by a New Streptomyces Bacteriophage, ϕJoe. Appl Environ Microbiol (2017) 0.75
In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc Natl Acad Sci U S A (1998) 5.04
Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev (1991) 5.02
Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors. J Bacteriol (2002) 4.75
The actinomycete-genus Rhodococcus: a home for the "rhodochrous" complex. J Gen Microbiol (1977) 2.75
Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi. Infect Immun (1991) 2.52
Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi. J Clin Microbiol (1991) 2.44
Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis (1991) 1.80
Survival and replication of Rhodococcus equi in macrophages. Infect Immun (1994) 1.76
Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect Immun (1999) 1.73
The streptomyces genome contains multiple pseudo-attB sites for the (phi)C31-encoded site-specific recombination system. J Bacteriol (2002) 1.57
Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity. Can J Vet Res (1995) 1.57
Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet Microbiol (1987) 1.40
Deletion of vapA encoding Virulence Associated Protein A attenuates the intracellular actinomycete Rhodococcus equi. Mol Microbiol (2003) 1.37
Pathogenesis and virulence of Rhodococcus equi. Vet Microbiol (1997) 1.33
Identification and mutagenesis by allelic exchange of choE, encoding a cholesterol oxidase from the intracellular pathogen Rhodococcus equi. J Bacteriol (2001) 1.32
Maturation of Rhodococcus equi-containing vacuoles is arrested after completion of the early endosome stage. Traffic (2005) 1.32
Phenotypic mutants of the intracellular actinomycete Rhodococcus equi created by in vivo Himar1 transposon mutagenesis. J Bacteriol (2003) 1.20
Analysis of virulence plasmid gene expression of intra-macrophage and in vitro grown Rhodococcus equi ATCC 33701. Vet Microbiol (2003) 1.04
Intergeneric conjugal transfer of plasmid DNA from Escherichia coli to Kitasatospora setae, a bafilomycin B1 producer. Arch Microbiol (2004) 1.01
Isocitrate lyase activity is required for virulence of the intracellular pathogen Rhodococcus equi. Infect Immun (2005) 1.00
Random insertion mutagenesis of the intracellular pathogen Rhodococcus equi using transposomes. FEMS Microbiol Lett (2001) 0.97
Development of a Rhodococcus equi-Escherichia coli plasmid shuttle vector. Plasmid (1997) 0.96
Transcriptional regulation of the virR operon of the intracellular pathogen Rhodococcus equi. J Bacteriol (2007) 0.93
Pirin regulates pyruvate catabolism by interacting with the pyruvate dehydrogenase E1 subunit and modulating pyruvate dehydrogenase activity. J Bacteriol (2006) 0.89
Versatile Rhodococcus equi-Escherichia coli shuttle vectors. Antonie Van Leeuwenhoek (2005) 0.87
A new site-specific integration system for mycobacteria. Tuberculosis (Edinb) (2005) 0.86
Improved electroporation of Rhodococcus equi. J Vet Med Sci (1998) 0.85
Molecular weapons against agricultural vulnerability and the war on terror. J Vet Med Educ (2003) 0.77
Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth. Proc Natl Acad Sci U S A (2002) 2.41
Deletion of vapA encoding Virulence Associated Protein A attenuates the intracellular actinomycete Rhodococcus equi. Mol Microbiol (2003) 1.37
Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs. Infect Immun (2004) 1.34
Phenotypic mutants of the intracellular actinomycete Rhodococcus equi created by in vivo Himar1 transposon mutagenesis. J Bacteriol (2003) 1.20
Reductive stress in microbes: implications for understanding Mycobacterium tuberculosis disease and persistence. Adv Microb Physiol (2010) 0.92
Innate immune responses to Rhodococcus equi. J Immunol (2004) 0.91
Characterization of the role of the pathogenicity island and vapG in the virulence of the intracellular actinomycete pathogen Rhodococcus equi. Infect Immun (2010) 0.91
Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate. Vaccine (2011) 0.86
The hydroxamate siderophore rhequichelin is required for virulence of the pathogenic actinomycete Rhodococcus equi. Infect Immun (2012) 0.84
IcgA is a virulence factor of Rhodococcus equi that modulates intracellular growth. Infect Immun (2014) 0.81
Dry-powder pulmonary insufflation in the mouse for application to vaccine or drug studies. Tuberculosis (Edinb) (2009) 0.80
Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi. J Antimicrob Chemother (2016) 0.75